• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    1.57 Down 0.04(2.48%) Feb 5, 4:00PM EST
    |After Hours : 1.57 0.00 (0.00%) Feb 5, 4:57PM EST
    Prev Close:1.61
    Open:1.57
    Bid:1.52 x 1000
    Ask:1.65 x 700
    1y Target Est:5.50
    Beta:0.984398
    Earnings Date:Feb 29 - Mar 4 (Est.)
    Day's Range:1.54 - 1.66
    52wk Range:1.30 - 5.12
    Volume:2,314,979
    Avg Vol (3m):2,889,040
    Market Cap:380.80M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 2.48%380.80M
    OREXDown 2.65%267.62M
    GSKDown 0.54%98.64B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Dec-15) :-0.13
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback